TB Alliance Activity

$48M USD

Funder	Department of State
Recipient Organization	Global Alliance for TB Drug Development
Country	World
Start Date	Jun 07, 2021
End Date	Feb 10, 2025
Duration	1,344 days
Number of Grantees	14
Roles	Recipient
Data Source	US Foreign Aid
Grant ID	`219731-76`

Grant Description

The activity will support research studies to evaluate the safety and efficacy of novel TB drugs and treatment regimens, including the development and regulatory authority approval of compounds or regimens in clinical phase development. The goal of this activity is to support the discovery of better, faster-acting, and affordable TB drugs.